The latest closing stock price for Organogenesis as of January 31, 2025 is 3.68.
An investor who bought $1,000 worth of Organogenesis stock at the IPO in 2019 would have $-726 today, roughly -1 times their original investment - a -19.42% compound annual growth rate over 6 years.
The all-time high Organogenesis stock closing price was 150.00 on January 11, 2019.
The Organogenesis 52-week high stock price is 4.57, which is 24.2% above the current share price.
The Organogenesis 52-week low stock price is 2.17, which is 41% below the current share price.
The average Organogenesis stock price for the last 52 weeks is 3.01.
An investor who bought $1,000 worth of Organogenesis stock at the IPO in 2019 would have $-726 today, roughly -1 times their original investment - a -19.42% compound annual growth rate over 6 years.
The all-time high Organogenesis stock closing price was 150.00 on January 11, 2019.
The Organogenesis 52-week high stock price is 4.57, which is 24.2% above the current share price.
The Organogenesis 52-week low stock price is 2.17, which is 41% below the current share price.
The average Organogenesis stock price for the last 52 weeks is 3.01.